Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEMIPLIMAB vs CENEGERMIN-BKBJ: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CEMIPLIMAB vs CENEGERMIN-BKBJ: Safety Overview

Metric CEMIPLIMAB CENEGERMIN-BKBJ
Total FAERS Reports 1,020 11,919
Deaths Reported 175 199
Death Rate 17.2% 1.7%
Hospitalizations 651 736
Average Patient Age 68.9 yrs 68.5 yrs
% Female Patients 36.6% 70.3%
Manufacturer Regeneron Pharmaceuticals, Inc. N/A
Route INTRAVENOUS N/A
Marketing Status N/A Prescription